Business
Manufacturing partnership with Oragenics, Inc.
Manufacturing partnership with Oragenics, Inc..
About this update from Ekf Diagnostics Holdings Plc
[{"type":"text","content":"\n \nRNS Number : 0925V EKF Diagnostics Holdings PLC 19 July 2018 \n\n \nThis announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR).\n \nEKF Diagnostics Holdings plc\n(\"EKF\", the \"Company\")\n \nManufacturing partnership with Oragenics, Inc.\n \nEKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that it has signed an exclusive agreement with Oragenics, Inc. (NYSE American: OGEN), a Florida-based biopharmaceutical company, for the manufacturing of Oragenics' lantibiotic bulk drug substances in the United States.\n \nOragenics is developing a pipeline of novel therapeutics to address the rise in drug-resistant infectious diseases as well as oral mucositis. Under the collaboration agreement, EKF Diagnostics will manufacture compounds intended for preclinical and early stage clinical trials. Manufacturing will be completed at EKF's Elkhart enzyme production facility in Indiana, USA.\n \nIt is estimated that the partnership should generate multi-million dollars in revenues to EKF Diagnostics over the duration of the manufacturing agreement.\n \nJulian Baines, CEO of EKF commented: \"We are delighted to partner with Oragenics in the development of lantibiotics. EKF has invested heavily in the Elkhart facility and we are now in a position to attract high quality pharmaceutical partners such as Oragenics.\"\n \nDr. Alan Joslyn, CEO and President of Oragenics added: \"We are excited to partner with EKF Diagnostics for the manufacturing of our novel lantibiotics in the United States. We believe this agreement will enable Oragenics to continue development of our early stage lantibiotic programs, which potentially will be able to address multi-drug resistant infections such as C. difficile.\"\n \nEnquiries:\n \n\n\n\nEKF Diagnostics Holdings plc \n\n\nwww.ekfdiagnostics.com\n\n\n\n\nChristopher Mills, Non-Executive Chairman\n\n\nTel: 029 2071 0570\n\n\n\n\nJulian Baines, CEO \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRichard Evans, FD & COO\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nN+1 Singer (Nomad & Broker)\n\n\nTel: 020 7496 3000\n\n\n\n\nAubrey Powell / Shaun Dobson\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Limited\n\n\nTel: 020 7933 8780 or&...